Roivant Sciences Ltd (ROIV)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 361 |
| % of all portfolios: | 0.059% |
| Hold Price * : | $10.54 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 4,190,490 | 2.02 | |
| Q4 2023 | |||||
| ≡ | Viking Global Investors | Reduce 5.54% | 4,065,340 | 0.17 | |
| Q3 2023 | |||||
| ≡ | Viking Global Investors | Reduce 2.40% | 1,804,399 | 0.09 | |
| Q2 2023 | |||||
| ≡ | Viking Global Investors | Reduce 14.73% | 13,000,000 | 0.54 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Buy | 88,238,700 | 2.58 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.